158 related articles for article (PubMed ID: 32056419)
41. Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation.
Kurosawa S; Toya T; Kishida Y; Nagata A; Yamada Y; Konishi T; Kaito S; Yoshifuji K; Matsuyama N; Shirane S; Uchida T; Inamoto K; Igarashi A; Najima Y; Muto H; Kobayashi T; Doki N; Kakihana K; Sakamaki H; Ohashi K
Leuk Lymphoma; 2018 Dec; 59(12):3006-3009. PubMed ID: 29616841
[No Abstract] [Full Text] [Related]
42. Successful treatment of pulmonary mucormycosis in two pediatric hematopoietic stem cell transplant patients.
Elgarten CW; Levy EM; Mattei P; Fisher BT; Olson TS; Freedman JL
Pediatr Transplant; 2018 Nov; 22(7):e13270. PubMed ID: 30014584
[TBL] [Abstract][Full Text] [Related]
43. [Refractory ascites caused by lymphatic flow disorder after stem cell transplantation for acute myeloid leukemia].
Takakuwa T; Okuno T; Nishimoto M; Nanno S; Takeoka Y; Nakashima Y; Koh H; Nakane T; Wanibuchi H; Hino M; Nakamae H
Rinsho Ketsueki; 2019; 60(1):12-16. PubMed ID: 30726817
[TBL] [Abstract][Full Text] [Related]
44. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
[No Abstract] [Full Text] [Related]
45. NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia.
Terwey TH; Vega-Ruiz A; Hemmati PG; Martus P; Dietz E; le Coutre P; Massenkeil G; Dörken B; Arnold R
Leukemia; 2012 Mar; 26(3):536-42. PubMed ID: 21869841
[No Abstract] [Full Text] [Related]
46. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group.
Basara N; Baurmann H; Kolbe K; Yaman A; Labopin M; Burchardt A; Huber C; Fauser AA; Schwerdtfeger R
Bone Marrow Transplant; 2005 May; 35(10):1011-8. PubMed ID: 15821768
[TBL] [Abstract][Full Text] [Related]
47. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
[No Abstract] [Full Text] [Related]
48. Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML.
Legrand F; Le Floch AC; Granata A; Fürst S; Faucher C; Lemarie C; Harbi S; Bramanti S; Calmels B; El-Cheikh J; Chabannon C; Weiller PJ; Vey N; Castagna L; Blaise D; Devillier R
Bone Marrow Transplant; 2017 Apr; 52(4):620-621. PubMed ID: 27941765
[No Abstract] [Full Text] [Related]
49. Rapid Onset of Hypoxemia in a Man with Graft-versus-Host Disease after Stem Cell Transplant Leukemia.
Karamooz E; Nguyen N; Gold JA
Ann Am Thorac Soc; 2017 Feb; 14(2):283-287. PubMed ID: 28146374
[No Abstract] [Full Text] [Related]
50. Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Medinger M; Heim D; Gerull S; Halter J; Krenger W; Buser A; Lengerke C; Bucher C; Passweg J
Leuk Res; 2016 Aug; 47():22-5. PubMed ID: 27239737
[TBL] [Abstract][Full Text] [Related]
51. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
[TBL] [Abstract][Full Text] [Related]
52. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
53. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.
Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A
J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518
[TBL] [Abstract][Full Text] [Related]
54. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A
Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924
[TBL] [Abstract][Full Text] [Related]
55. Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.
Ciurea SO; Labopin M; Socie G; Volin L; Passweg J; Chevallier P; Beelen D; Milpied N; Blaise D; Cornelissen JJ; Fegueux N; Polge E; Kongtim P; Rondon G; Esteve J; Mohty M; Savani BN; Champlin RE; Nagler A
Cancer; 2018 May; 124(10):2134-2141. PubMed ID: 29469961
[TBL] [Abstract][Full Text] [Related]
56. GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies.
Nazha A; Rybicki L; Abounader D; Bolwell B; Dean R; Gerds AT; Jagadeesh D; Hamilton BK; Hill BT; Kalaycio M; Liu H; Pohlman B; Sobecks R; Sekeres MA; Majhail NS
Bone Marrow Transplant; 2016 Dec; 51(12):1642-1643. PubMed ID: 27721371
[No Abstract] [Full Text] [Related]
57. [Treatment outcome of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies not in remission].
Bao HY; Wu XJ; Ma X
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):156-7. PubMed ID: 22780938
[No Abstract] [Full Text] [Related]
58. Pulmonary Nocardia nova infection after allogeneic hematopoietic stem cell transplantation.
Yamakawa H; Yoshida M; Morikawa N; Fujimoto S; Ishikawa T; Sano K; Nishiwaki K; Takagi M; Hayashi M; Kuwano K; Aiba K
Intern Med; 2014; 53(12):1391-5. PubMed ID: 24930664
[TBL] [Abstract][Full Text] [Related]
59. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
60. Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis.
Schneidawind D; Nann D; Vogel W; Faul C; Fend F; Horger M; Kanz L; Bethge W
Transpl Infect Dis; 2012 Dec; 14(6):E166-72. PubMed ID: 23075207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
